Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-168-8 | CAS number: 1761-71-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Specific investigations: other studies
Administrative data
Link to relevant study record(s)
Description of key information
A human scleroderma or morphea syndrome in epoxy workers has been brought to the attention of the medical community in Japan in the 1980's. One substance from among many was investigated in an animal experiment, of 10-28 days repeated dose oral exposure in Fisher rats at doses ranging from 25 to 100 mg/kg bw/d. A degenerative myopathy was found at doses of 50 mg/kg bw/d and higher, and electron microscopy refined the pathology. No scleroderma syndrome was seen after this exposure. An association of 4-4’-methylenedicyclohexanamine in a causal relationship to this syndrome has not been proven. The lack of attention to this effect among the industry having a history of heavy use of epoxy resins argues that the Japanese experience may have been an isolated event unassociated with this substance.
Additional information
Amine curing agents were suspected of causing human muscle disorders in workers in Japan, based on case studies of several workers in an epoxy resin polymerization factory, as reported by Yamakage, 1980, 1982. These have been described as scleroderma or morphea-type syndromes. One component of the agents used in the factory is 4-4’-methylenedicyclohexanamine, which was tested by Ohshima (1984, 1986) in a 28-day oral subchronic study with Fisher rats at doses of 25, 37.5, 50 and 75 mg/kg bw/d. Animals were monitored for clinical signs, body and organ weight changes. Clinical chemistry, hematology, and histopathologic examinations were made in selected organs and muscles. A second experiment utilized higher doses (100 mg/kg bw/d) for up to 10 days, and electron microscopy was used to examine tissue. Results indicate that animals receiving 75 mg/kg bw/d and higher doses showed suppression of body weight gain, weakness of the limb muscles, and minor changes in hematology and clinical chemistry parameters. There were few biochemical endpoints which supported muscle degeneration (no increase in CPK levels or blood protein levels). Histological examination showed no remarkable changes in most tissues (liver, kidney, spleen, heart, etc.), nor was there a reconstitution of a scleroderma or morphea-type syndrome. However, skeletal muscles showed various degrees of atrophy and degeneration or regenerative changes of muscle fibers. Electron microscopy revealed myofibril disruption, dilatation of the sarcoplasmic reticulum or mitochondria and the presence of inclusion bodies of a lamellar structure. The doses at which these effects were noted was not well described in the publication, but there were no effects described at 37.5 mg/kg bw/day or lower, hence this value is determined to be the NOAEL. It is questionable whether the muscle effect seen with one isolated chemical (4-4’-methylenedicyclohexanamine) from among many used in the factory would be the cause of the scleroderma syndrome in workers. In fact, Yamakage (1982) later proposed that this may be the result of solvent exposure, in general. There was no comprehensive assessment of chemical exposures of the workers, no report on the nutritional status or lifestyle behaviours of the workers, and no history or biochemical measurement of infectious diseases or genetic syndromes. This effect has not been reported, to our knowledge, by others who have a strong history of use of epoxy resins.
In summary, while the report of a scleroderma or morphea syndrome in epoxy workers has been brought to the attention of the medical community, the association of 4-4’-methylenedicyclohexanamine in a causal relationship to this syndrome has not been proven. The lack of attention to this effect among the industry having a history of heavy use of epoxy resins argues that this may have been an isolated event unassociated with this substance.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.